8 rezultatov
This invention relates to a novel class of ergot alkaloid derivatives with selective antagonistic properties to 5-HT.sub.2 receptors for the prevention of, and relief from, migraine-related headache, Parkinson's disease, disorders of the thrombocyte function, etc.
BACKGROUND AND STATE OF THE
The present invention relates to acid addition salts of dextrorotatory ergot alkaloids, a process for the preparation thereof as well as their use as medicines.
More particularly, the present invention relates to acid addition salts of ergotaminine, ergosinine, ergocryptinine, ergocristinine and
BACKGROUND OF THE INVENTION
The present invention is directed to methods and formulations for treating migraines, muscle sprains, muscle spasms, spasticity, tension headache, tension-related migraines and related conditions associated with muscle tension and pain.
Migraine headaches are a
Throughout this application, various publications are referenced. Disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
FIELD OF THE INVENTION
This
Throughout this application, various publications are referenced. Disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
FIELD OF THE INVENTION
This
FIELD OF THE INVENTION
This invention relates to extracts from a plant called Wenguanguo (Xanthoceras Sorbifolia Bunge), their usages and functions, and methods of their preparation.
BACKGROUND OF THE INVENTION
Wenguanguo is a species of the sapindaceae family. Its scientific name is Xanthoceras
FIELD OF THE INVENTION
This invention relates to extracts from a plant called Wenguanguo (Xanthoceras Sorbifolia Bunge), their usages and functions, and methods of their preparation.
BACKGROUND OF THE INVENTION
Wenguanguo is a species of the sapindaceae family. Its scientific name is Xanthoceras
BACKGROUND OF THE INVENTION
This invention relates to a method and composition for treating migraine. More particularly, this invention is concerned with alleviating a migraine by administration of an antimigraine drug together with a nontoxic antagonist, or blocker, for the N-methyl-D-aspartate